跳至主要内容
临床试验/NCT00790569
NCT00790569已完成不适用

Varenicline Versus Nicotine Replacement for Methadone-Maintained Smokers

Butler Hospital1 个研究点 分布在 1 个国家目标入组 315 人开始时间: 2008年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
315
试验地点
1
主要终点
Self- Reported 7-day Abstinence

研究概览

简要总结

RATIONALE: Varenicline, the nicotine patch, and nicotine gum help people stop smoking. It is not yet known whether varenicline is more effective than the nicotine patch given together with nicotine gum in helping smokers quit smoking.

PURPOSE: This randomized clinical trial is studying varenicline to see how well it works compared with the nicotine patch given together with nicotine gum in helping smokers in a methadone treatment program stop smoking.

详细描述

OBJECTIVES:

Primary

  • To determine whether varenicline, a nicotine receptor partial agonist, leads to a higher rate of smoking cessation than combination nicotine replacement therapy with nicotine patch prescription plus ad libitum nicotine gum delivery in methadone-maintained smokers.

Secondary

  • To test the effects of the treatments on smoking urges, withdrawal symptoms, and reinforcing effects of smoking.
  • To test the effects of the treatments on methadone treatment outcomes, including retention in methadone maintenance, methadone dose changes, and continued use of illicit drugs as measured by urine toxicologies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Arm I

Experimental

Patients receive oral varenicline once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached.

干预措施: varenicline (Drug)

Arm II

Placebo Comparator

Patients receive oral varenicline placebo once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached.

干预措施: placebo (Other)

Arm III

Active Comparator

Patients receive a nicotine patch, with doses tapering over time for a total of 26 weeks. Patients also receive nicotine gum to quell breakthrough urges. Patients may stop treatment when a comfortable level of smoking abstinence is reached.

干预措施: nicotine (Drug)

结局指标

主要结局

Self- Reported 7-day Abstinence

时间窗: 6 Months

Number of participants with self-reported, 7-day abstinence at 6-months

Carbon Monoxide (CO)-Confirmed 7-day Abstinence

时间窗: 6-Months

Number of participants reporting 7-day abstinence at 6-months, confirmed with CO measurement.

Rates of Smoking Cessation Continuous From First Quit Day to 6 Months

时间窗: 6-Months

Number of participants who self-reported continuous abstinence from their initial quit day (study day 14) to 6 Months

Self-reported 7-day Abstinence

时间窗: 12 Months

Number of participants with self-reported 7-day abstinence at 12-months

CO-confirmed 7-day Abstinence

时间窗: 12 Months

Number of participants reporting 7-day abstinence at 12-months, confirmed with CO measurement.

次要结局

  • Change in Cigarettes Per Day(6-Months)
  • Change in Smoking Urges(6 months)
  • Withdrawal Symptoms(6 months)
  • Retention in Methadone Maintenance(12 months)
  • Methadone Dose Changes(12 months)
  • Use of Illicit Drugs as Measured by Urine Toxicologies(12 months)
  • Reinforcing Effects of Smoking(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Stein, MD

Principal Investigator

Butler Hospital

研究点 (1)

Loading locations...

相似试验